SUDDEN – Sustainable Drug Discovery and Development with End-of-Life Yield

Leading organisations:
University of Helsinki

Timeframe:
2018-2021

Geographic Area:

Objectives:

-Research project that aims at reducing the environmental hazards related to the life cycle of pharmaceuticals.
-To enhance the sustainability of the pharmaceutical industry.


Target audience:
Environmental experts, National/Local decision and policy makers, and Pharmaceutical manufacturers

Area of interest:
Pharmaceutical consumption by humans, Pharmaceutical manufacturing, Pharmaceutical waste & waste management, and Water treatment technologies

Activities:

1) Will develop tools, solutions and policy recommendations which will create possibilities for sustainable growth by solving environmental issues in the life-cycle of a pharmaceutical.


Communication material:

Return to search form.

HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE+ programme, the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (BMU) Germany, and the German Environment Agency (UBA). HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC, BMU, or UBA.